Prime moves to acquire Calumet Coach
Prime Medical Services has agreed in principle to acquire the assets of Calumet Coach. The acquisition will be made through Prime's manufacturing subsidiary, AK Associates, and is subject to the preparation of definitive documents and the completion of
Prime Medical Services has agreed in principle to acquire the assets of Calumet Coach. The acquisition will be made through Prime's manufacturing subsidiary, AK Associates, and is subject to the preparation of definitive documents and the completion of customary approvals. Terms were not disclosed. Privately held Calumet designs, engineers, and constructs vehicles to transport medical, broadcast, and special-purpose products. Prime operates a fleet of 67 mobile lithotriptors and 15 (stationary) refractive surgery centers in 34 states.
© 2001 Miller Freeman Inc.
3/28/01, Issue # 1506, page 4.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
